LORD, ABBETT & CO. LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$23,788
+20.2%
1,197,182
+3.6%
0.08%
+15.5%
Q1 2023$19,791
+88.8%
1,155,338
+115.7%
0.07%
+86.8%
Q4 2022$10,482
-99.9%
535,588
+0.1%
0.04%
+22.6%
Q3 2022$8,538,000
+135.1%
534,949
+102.7%
0.03%
+138.5%
Q2 2022$3,632,000
-6.8%
263,931
+7.4%
0.01%
+30.0%
Q1 2022$3,897,000
-86.2%
245,692
-80.9%
0.01%
-84.4%
Q4 2021$28,139,000
-22.2%
1,289,005
+6.6%
0.06%
-25.6%
Q3 2021$36,154,000
-50.5%
1,209,568
-26.6%
0.09%
-51.1%
Q2 2021$73,011,000
-0.4%
1,648,471
-0.2%
0.18%
-5.9%
Q1 2021$73,308,000
-15.9%
1,652,194
+3.9%
0.19%
-18.7%
Q4 2020$87,198,000
+139.7%
1,590,052
-0.1%
0.23%
+98.3%
Q3 2020$36,379,000
+30.0%
1,591,395
+19.1%
0.12%
+18.4%
Q2 2020$27,978,000
+32.5%
1,336,722
-11.7%
0.10%
+4.3%
Q1 2020$21,111,000
-9.1%
1,513,354
+48.3%
0.09%
+22.1%
Q4 2019$23,228,000
+369.4%
1,020,534
+140.3%
0.08%
+352.9%
Q3 2019$4,948,000
-27.3%
424,713
-6.3%
0.02%
-22.7%
Q2 2019$6,802,000
+21.1%
453,480
+41.6%
0.02%
+15.8%
Q1 2019$5,619,000
+15.6%
320,361
-2.3%
0.02%
+5.6%
Q4 2018$4,861,000
-52.2%
327,953
-20.5%
0.02%
-35.7%
Q3 2018$10,162,000
+45.2%
412,736
+15.8%
0.03%
+40.0%
Q2 2018$6,998,000356,5140.02%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders